RN
Rupesh Narayanrao Bobade
About Rupesh Narayanrao Bobade
Data last updated:
Rupesh Narayanrao Bobade has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Roykar Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Roykar Pharmaceuticals Private Limited at ₹97,800 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Roykar Pharmaceuticals Private Limited U24232PN2015PTC155790 | Director | 15 Jul 2015 | 2015 | ₹97,800 (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupesh Narayanrao Bobade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupesh Narayanrao Bobade
Rupesh Narayanrao Bobade has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Roykar Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Roykar Pharmaceuticals Private Limited at ₹97,800 (FY 2025).
Rupesh Narayanrao Bobade is associated with 1 company as Director, including Roykar Pharmaceuticals Private Limited (₹97,800).
Rupesh Narayanrao Bobade has expertise in General Business.
Rupesh Narayanrao Bobade has 11 years in corporate governance.
By reported revenue, the largest current company of Rupesh Narayanrao Bobade is Roykar Pharmaceuticals Private Limited, with revenue of ₹97,800 (FY 2025).
Rupesh Narayanrao Bobade currently holds positions at 1 company: Roykar Pharmaceuticals Private Limited (₹97,800).